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Abstract
Introduction
Breast cancer has a high prevalence in the community and places very high demands on
resources. Digital mammography provides a good quality image with reduced radiation dose
and can detect breast carcinoma in its earlier stages, resulting in good prognosis and improved
patient survival.

Objective
To calculate the diagnostic accuracy of digital mammography in the detection of breast cancer,
using histopathology as a gold standard in women aged over 30 years, who are undergoing
mammography for screening and diagnostic purposes.

Materials and methods
This was a cross-sectional analytical study, conducted in the department of radiology, for a
total duration of 10 months. A total of 122 patients of age above 30 years, referred for digital
mammography for the evaluation of different symptoms related to breast diseases, followed by
biopsy/surgery and histopathology, were included in the study.

Result
Our data confirmed that digital mammography is a highly accurate tool for breast cancer
detection having a sensitivity of 97%, a specificity of 64.5%, a positive predictive value of 89%,
and a negative predictive value of 90.9%, with a diagnostic accuracy of 89.3%.
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Conclusion
Considering our results, we recommend that digital mammography should replace screen-film
mammography as a basic tool to detect breast cancer for both screening and diagnostic
purposes.

access article distributed under the
terms of the Creative Commons
Attribution License CC-BY 3.0.,
which permits unrestricted use,
distribution, and reproduction in any
medium, provided the original

Categories: Pathology, Radiology, Quality Improvement
Keywords: breast cancer, digital mammography, spiculated density, pleomorphic microcalcifications,
architectural distortion, skin thickening, nipple retraction

author and source are credited.

How to cite this article
Zeeshan M, Salam B, Khalid Q B, et al. (April 08, 2018) Diagnostic Accuracy of Digital Mammography in
the Detection of Breast Cancer. Cureus 10(4): e2448. DOI 10.7759/cureus.2448

Introduction
Breast cancer is the most common cancer in females in the United States and throughout the
world. It is responsible for 21% of new cancer cases worldwide [1]. It is also prevalent among
women in Pakistan (accounting for one-third of the cancers in females) [2]. The five-year
survival of stage IV breast cancer is 10%. However, earlier detection and treatment can improve
five-year survival to 85% [1].
A study conducted by Karin Flobbe et al. in the Netherlands has estimated the prevalence of
breast cancer to be 6.3%, which is consistent with the results of other studies [3]. Breast cancer
detection via mammography has been recommended traditionally and the majority of women
older than 40 years in the United States participate [4]. Recent research conducted on 210,000
women in Sweden has shown that in women aged 40-49 years, there was a significant 48%
reduction in breast cancer mortality in those exposed to screening, whereas there was none in
those unscreened [5].
Both screen-film mammography and digital mammography use x-rays to obtain images. With
screen-film mammography, the image is captured on film; with digital mammography, the
image is captured digitally [6]. Digital mammography is developed to address the limitations of
film mammography and separates image acquisition and display, allowing the optimization of
both [7].
In many recent studies, digital mammography was significantly better than conventional film
mammography at detecting breast cancer in young women, premenopausal and
perimenopausal women, and women with dense breasts [8]. The visibility of a subtle mass or
cluster of microcalcifications present in the image can be increased if image contrast is
adjusted [9]. Approximately 25-43% of non-palpable cancers are detected on mammography
because of microcalcifications [10].
Digital mammography also offers other benefits over film mammography in the form of easier
access to images and computer-assisted diagnosis; improved means of transmission, retrieval,
and storage of images; and the use of a lower average dose of radiation without compromising
diagnostic accuracy [7].
Pisano et al., in one of their studies, calculated the sensitivity and specificity of digital
mammography to be 85% and 90%, respectively, in females aged less than 50 years and pre- or
perimenopausal women with non-dense breasts [11].
The aim of this study is to calculate the diagnostic accuracy of digital mammography in
detecting breast cancer early, using histopathology as the gold standard in women aged over 30
years who are undergoing mammography for screening and diagnostic purposes.
As the early detection of breast cancer increases the chances of cure and subsequently improves
quality of life, this study will provide a landmark for other institutions to acquire and use digital
mammography equipment for screening purposes.

Materials And Methods
This was a cross-sectional analytical study conducted in the department of radiology, for a total
duration of 10 months. The sampling technique was non-probability, purposive. The sample
size was calculated using sample size determination in the health studies manual by WHO. The
reported sensitivity of a digital mammogram to detect breast cancer is 85% and the reported
specificity is 90% [11]. The prevalence of breast cancer is 20% (one in five female patients). The
desired precision is 12%, so 121 patients were the required sample. We included 122 patients in
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the study.
All female patients above 30 years of age referred to the radiology department for digital
mammography followed by biopsy were included. Patients who were already diagnosed with
breast cancer and underwent digital mammography for follow-up and those patients who had
inconclusive mammograms due to increased breast density and needed an ultrasound for
further evaluation were excluded. Similarly, patients whose histopathology results were not
available or they did not undergo biopsy/surgery were also excluded.
Informed consent was taken for the examination and inclusion in the study. After explaining
the procedure, a brief history was taken regarding the patient’s signs and symptoms, their
duration, and any family history of breast cancer. Mammograms were performed on
Mammomat Nova 3000 (Siemens AG, Munich, Germany) at 26-30 Kvp and mAs were set on
automatic exposure control. Automatic exposure control is a default setting in digital
mammographic equipment to control the exposure and is calibrated by an experienced
physicist having a minimum of five years' experience.
Images were acquired in the mediolateral oblique and craniocaudal projections. When needed,
additional views, such as exaggerated view, axillary view, magnified view, and cone
compression view, were taken. The digital mammograms were analyzed by a post-graduate
consultant radiologist with minimum five years' experience, while the histopathology results
were provided by a post-graduate consultant pathologist with minimum five years' experience,
which served as the gold standard. The findings of digital mammography, histopathology, and
demographics were entered in the proforma by the researcher.
The patient’s data were collected using a standard proforma. Data entry and analysis were done
through IBM SPSS for Windows, version 19.0 (IBM Corp, Armonk, NY). Descriptive statistics
were calculated. Mean and standard deviation were calculated for the age of the patient.
Frequencies and percentages were calculated for the site of the lesion in the breast, any family
history of breast cancer, the associated pleomorphic microcalcifications, architectural
distortion, skin thickening and nipple retraction, and presence or absence of axillary lymph
nodes.
Confounding variables, like age, family history of breast cancer, and use of hormone
replacement therapy (HRT), were dealt with in data analysis and stratification was done to see
the effect of these on the outcome variable.
A 2x2 table was used to calculate sensitivity, specificity, positive predictive value, negative
predictive value, and diagnostic accuracy. Sensitivity, specificity, positive and negative
predictive values, and diagnostic accuracy of digital mammography in the detection of breast
cancer were calculated against histopathology as the gold standard, as defined in the
operational definition.

Results
A total of 122 patients were included in our study according to inclusion and exclusion criteria,
with a mean age of 50.79 years (SD +/- 12.06). Among these patients, spiculated density in the
mammograms was present in 88 patients (72.1%) (Figure 1).
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FIGURE 1: Mediolateral-oblique (MLO) and cranial-caudal (CC)
views in a patient with spiculated density (arrow), architectural
distortion, skin thickening, and nipple retraction of the left
breast, proven to be breast carcinoma on histopathology (true
positive).

The sizes of the spiculated density were grouped into either less than two cm or greater than
two cm. No spiculated lesion was found in 27.9% of the patients. Lesions that were < 2 cm in
size were 18.9% and those > 2 cm were 53.3%. The most common observed site of the lesion was
the right upper-outer quadrant 40 (32.8%), followed by the left upper-outer quadrant 34
(27.9%). The pleomorphic microcalcification seen was present in 34 patients (28%) and was
absent in 88 (72%). Architectural distortion was seen in 45 patients (36.9%) and was absent in
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77 patients (63.1%). Skin features, such as skin thickening and nipple retraction, were present
in 22 (18%) and 10 (8.2%) patients, respectively. Axillary lymph nodes were present in 106
patients (86.9%). Similarly, breast cancer in mammograms was present in 100 patients (82%)
(Figure 2).
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FIGURE 2: Mediolateral-oblique (MLO) and cranial-caudal (CC)
views in a patient having pleomorphic microcalcifications in
the upper-outer quadrant of the left breast with enlarged dense
axillary lymph nodes, proven to be breast carcinoma on
histopathology (true positive).

The frequencies of different histopathological features, such as atypical cells, increased mitotic
activity, and hyperchromasia were present in 74.6% of the patients and were absent in 25.4%.
A diagnosis of breast cancer on histopathology was seen in 91 patients (74.6%).
Diagnostic accuracy was calculated as follows:
Sensitivity = True Positive (89)/True Positive (89) + False Negative (2) x 100 = 97%
Specificity = True Negative (20)/False Positive (11) + True Negative (20) x 100= 64.5 %
Positive predictive value = True Positive (89)/True Positive (89) + False Positive (11)x100 = 89%
Negative predictive value = True Negative (20) / False Negative (2) + True Negative (20) x 100=
90.9%
Diagnostic accuracy = True Positive (89) + True Negative (20)/True Positive (89) + False Positive
(11) + False Negative (2) + True Negative (20) x 100= 89.3%
A family history of breast cancer was present in 10 patients (8.1%), out of which eight had
breast carcinoma (6.5%) and two did not have breast carcinoma (1.6%). The use of hormone
replacement therapy (HRT) was present in six patients (4.9%), out of which four had breast
carcinoma (3.2%) and two did not have breast carcinoma (1.6%).

Discussion
Breast cancer has a high prevalence in the community and places very high demands on
resources. Historically, ongoing efforts are made to detect it as early as possible by using
different clinical and imaging techniques. Self breast examination and routine clinical checkups are clinical ways of detecting breast cancer early. However, due to the occult nature of most
of the early breast cancers, imaging has a vital role to play.
The evolution of mammography dates back to 1913, when surgeon A Salomon conducted a
study on the correlation between x-ray findings and histopathology in 3000 mastectomy cases
[12]. Conventional mammograms have been replaced by digital mammography, which provides
good quality images using reduced radiation doses and can detect breast carcinoma in its
earlier stages, resulting in a good prognosis and improved patient survival.
In our study, a total of 122 patients were included according to the inclusion and exclusion
criteria. They had a mean age of 50.79 years (SD +/- 12.06) with a minimum age of 31 years and
a maximum age of 77 years. Out of the 122 patients, the highest number of patients belonged to
the age group between 50 and 60 years (38 patients). The second-highest number of patients
belonged to the age group 31-40 years (29 patients). The third-highest group was 40-50 years
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(25 patients). The patients who had breast cancer on a mammogram, which was later confirmed
on histopathology, were of ages ranging from 43-60 years. Iqbal et al., in their study on the
survival of patients having locally advanced breast cancer performed in a teaching hospital of
Lahore, Pakistan, described the median age of breast cancer patients as 45 years [13]. They also
described that most of the women were pre-menopausal, with a receptor-negative disease.
Similar statistics were described in other studies performed in developing countries [14].
We calculated the diagnostic accuracy of digital mammography in detecting breast cancer to be
89.3%, with a sensitivity of 97%, a specificity of 64.5%, a positive predictive value of 89%, and a
negative predictive value of 90.9%. Pisano et al., in 2008, performed a study and calculated the
sensitivity and specificity of digital mammography in different age groups after considering
their pre-, peri- or post-menopausal status and breast density [11]. In patients aged < 50 years
with a non-dense breast, the sensitivity was 85% with a specificity of 90% while in patients
aged > 50 years with non-dense breast, the sensitivity was 66% and specificity was 93% [11]. In
our study, the results were similar with a little less specificity, as the number of false positives
was high due to a greater degree of suspicion considering the increasing prevalence of breast
cancer in our country.
In this study, spiculated density was present in 34 patients (28%) and 27 patients were
confirmed to have breast carcinoma on histopathology (27/34, 79.4%). The remaining seven
patients having spiculated density on a digital mammogram were proven to have phyllodes
tumor (4/7), surgical scarring (2/7), and benign sclerosing lesion (1/7). Most of the patients
having spiculated density on digital mammograms had a palpable abnormality, while the
rest were detected incidentally. All patients having a palpable abnormality usually had
spiculated densities measuring more than two cm (62% cases). Ciato et al. calculated the
frequency of spiculated density in his study as 40% (159/397 patients) [15].
The frequency of spiculated density in our study was a little higher due to the late presentation
of the patients, as occurs in our country due to less awareness and low socioeconomic status.
The highest number of lesions was located in the right upper outer quadrant (40 cases; 32.8%)
with the second-most common location being the left upper-outer quadrant (34 cases; 27.9%),
emphasizing the fact of the occurrence of breast cancer commonly in the upper-outer quadrant.
This is consistent with the literature results, which also showed that lesions are more common
in the upper-outer quadrants. Naeem et al. shared their experience at Lady Reading Hospital,
where they included 46 patients having breast cancer; out of them, 26 had lesions in the upperouter quadrants (26/46, 56.5%) [16].
Pleomorphic microcalcifications were present in 34 cases (28%), out of which 29 (29/34; 85.2%)
cases were diagnosed as having breast carcinoma on histopathology. In the past, the literature
showed that pleomorphic microcalcification has a positive predictive value of 42% for the
detection of malignancy [17]. Our study results are showing a higher positive predictive value of
pleomorphic microcalcifications due to the use of digital mammography instead of screen-film
mammography, as the former has better contrast resolution and the ability to magnify images
digitally.
The indirect features suggesting breast cancer on digital mammograms are architectural
distortion, skin thickening, and nipple retraction; these were present in 45 patients (36.9%), 22
(18%), and 10 (8.2%) of patients, respectively.
Overall, our results are in concordance with studies done in the past regarding the frequencies
of different mammographic signs in the detection of breast carcinoma. Goedde et al., in his
study, found that spiculated density was present in 44% cases, followed by clustered
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microcalcifications in 25%, mass in 22%, and asymmetric density in 14% of the cases [18].
The presence of axillary lymph nodes on a digital mammogram is not an indicator of breast
carcinoma, as it can be seen in normal patients as well as patients having a different diagnosis
than breast cancer. Therefore, it is not a criterion for diagnosing breast cancer on
mammograms. We calculated the frequency of axillary lymph nodes presence in digital
mammograms, which was 87% in 122 patients.
Family history is an important risk factor in the development of breast cancer, especially at an
early age. We evaluated the frequency of positive family history in patients having breast
cancer, and out of 83 patients, eight had a positive family history (8/83; 9.63%). Similar results
have been quoted by past studies, including a study conducted by Chauhan et al., who in a
hospital-based descriptive study, calculated the frequency of family history in breast cancer to
be 8% [19]. Mai et al. calculated the sensitivity, specificity, and negative and positive predictive
values of positive family history for different body cancers in a population-based study. He
found that in breast cancer, family history has a sensitivity, specificity, positive predictive
value, and negative predictive value of 61.1%. 95%, 61.3%, and 95%, respectively [20].
Hormone replacement therapy (HRT) as a cause of breast cancer is a topic of great debate. It
has been postulated that it is associated with a higher incidence of breast cancer in
postmenopausal women. This has been based on evidence from three studies, the Collaborative
Reanalysis (CR), the Women's Health Initiative (WHI), and the Million Women Study (MWS),
which established the casual relationship. We calculated the frequency of HRT use in patients
with breast cancer, which was found to be four out of 87 patients (4/87; 4.59%). Czernichow et
al. performed a retrospective analysis on the database of Institute Curie where it was found
that 1482 patients used HRT for more than six months out of 6737 patients diagnosed with
breast cancer (1482/6737; 21.9%) [21]. This difference is because, in our country, hormone
replacement therapy is not very popular and not prescribed by physicians on a regular basis.
Considering our study results, we can safely advocate that digital mammography can replace
screen-film mammography in our country as well. The most important advantage of using
digital mammography is a reduction in the radiation dosage that used to occur with the screenfilm technique because of film retakes. Akhtar et al. conducted a study in our department in
2008 comparing the retake rates in conventional versus digital radiography. He concluded that
digital radiography had a significantly lower number of retakes (1%) in comparison to the
retakes performed in conventional radiography (5.5%) [22].
This study also validates the need for nationwide breast cancer screening programs starting
from the age of 40 years and above, as all the patients having breast cancer in our study fall in
the range of 44-60 years.
There are a few disadvantages of digital mammography over screen-film mammography. First,
the initial cost of installing the system is high as compared to screen-film mammography, but
in the long term, it is cost-effective. Second, because digital mammographic equipment
has been launched by different manufacturers all around the world, and they are based on
different kinds of technologies, it is hard to recommend which one type of digital
mammographic equipment should be used. As comparative data is not available yet, it is
impossible to recommend, at this point in time, the best digital mammography equipment to be
used for the best results [23].
In this study, we also recognized some limitations. First, we excluded those patients having
dense breast parenchyma from digital mammograms, as it reduces its sensitivity of detection by
digital mammography. But, we kept the heterogeneously dense breast parenchyma, which also
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reduces the sensitivity of digital mammograms. This might be the fact that may have resulted in
false negative cases. Second, we did not stratify the results according to breast density, as many
studies in the past have shown different diagnostic accuracies for different degrees of breast
density and patterns of parenchyma [11]. Third, we did not compare the diagnostic accuracies
of conventional screen-film mammography with those of digital mammography, as has been
done in the literature [7]. The fourth limitation is that we did not calculate the interobserver
variability, as the digital mammograms were interpreted by a single radiologist.

Conclusions
To summarize, our data confirmed that digital mammography is a highly accurate tool for
breast cancer detection, having a sensitivity of 97%, a specificity of 64.5%, a positive predictive
value of 89%, and a negative predictive value of 90.9%, with a diagnostic accuracy of 89.3%.
Digital mammography enjoys a few advantages over the film-screen conventional
mammography and is replacing the older technique all over the world. However, special
attention should be given while selecting equipment, as not much data is available for
reference.
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